Skip to content
Clinical Trials – home

Cytisinicline: A Promising Treatment for Smoking and Vaping Cessation

2 / 5
trials open to patients / all trials
3+
Countries

In short

Cytisinicline, also known as cytisine, is an investigational drug being studied in clinical trials for its potential to help people quit smoking. This article summarizes key findings from recent trials examining cytisinicline's safety, efficacy, and effects on smoking behavior and cravings.

At a glance

Drug Name
Cytisinicline (also known as cytisine)
Primary Use
Smoking cessation
Mechanism of Action
Targets α4β2 nicotinic acetylcholine receptors
Dosage in Trials
Typically 3 mg three times daily
Treatment Duration
6 to 12 weeks in most studies
Primary Outcomes
Smoking abstinence rates, verified by exhaled carbon monoxide levels
Secondary Outcomes
Continuous abstinence, relapse rates, craving reduction
Safety Assessments
Adverse events, vital signs, ECG changes, laboratory tests
Ongoing Research
Long-term efficacy, effects on neural substrates of cue-reactivity, use in special populations (e.g., renal impairment)

What is Cytisinicline?

Cytisinicline, also known as cytisine or Tabex, is a medication being studied for its potential to help people quit smoking and vaping. It is a plant-based compound that has been used in Eastern Europe for decades to aid in smoking cessation, but is now undergoing clinical trials in the United States and other countries to evaluate its safety and effectiveness.

How Does Cytisinicline Work?

Cytisinicline works by targeting specific receptors in the brain called nicotinic acetylcholine receptors, particularly the α4β2 subtype. These are the same receptors that nicotine acts on when a person smokes or vapes. By binding to these receptors, cytisinicline can: Reduce cravings for nicotine Lessen the pleasurable effects of smoking or vaping Alleviate withdrawal symptoms that often occur when trying to quit This mechanism of action helps make it easier for individuals to stop using tobacco or nicotine-containing e-cigarettes.

Conditions Treated by Cytisinicline

Cytisinicline is primarily being studied for: Smoking Cessation: Helping people quit smoking traditional cigarettes Vaping Cessation: Assisting individuals in stopping the use of e-cigarettes or vaping devices These conditions are often referred to as Tobacco Use Disorder when diagnosed by healthcare professionals.

Dosage and Administration

In most clinical trials, cytisinicline is being tested as an oral medication in the form of tablets or capsules. The typical dosage being studied is: 3 mg taken three times daily (abbreviated as TID) Treatment duration ranging from 6 to 12 weeks It's important to note that the optimal dosage and duration may vary depending on individual needs and the results of ongoing studies. Always follow the guidance of a healthcare professional when taking any medication.

Effectiveness of Cytisinicline

Several clinical trials are currently evaluating the effectiveness of cytisinicline for smoking and vaping cessation. Researchers are measuring: The proportion of participants who achieve smoking or vaping abstinence during treatment Continuous abstinence rates after treatment completion Relapse rates and long-term success in quitting While final results are still pending for many studies, early research suggests that cytisinicline may be an effective aid for those trying to quit smoking or vaping.

Safety and Side Effects

The safety profile of cytisinicline is being closely monitored in clinical trials. Some studies are specifically designed to evaluate: Treatment-emergent adverse events (side effects that occur after starting the medication) Effects on heart rhythm and other cardiac parameters How the medication is processed by the body, especially in people with kidney problems As with any medication, cytisinicline may cause side effects. The full range of potential side effects is still being studied, and patients in clinical trials are closely monitored for any adverse reactions.

Ongoing Research on Cytisinicline

Cytisinicline is the subject of numerous ongoing clinical trials, including: Studies comparing its effectiveness to placebo (a dummy pill with no active ingredient) Investigations into how food affects the absorption of the medication Research on its effects on brain activity related to smoking cues Evaluations of its potential for long-term use in preventing relapse These studies aim to provide a comprehensive understanding of cytisinicline's benefits, risks, and optimal use in helping people quit smoking and vaping.

Questions people often ask

Conditions where Cytisinicline is being studied

Each condition opens its own overview and trial list

Trials with Cytisinicline

Recruiting trials first

See all 5 →
Quick filters
  • Participants:Adults · Healthy volunteers
  • Participants:Adults · Healthy volunteers
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).